BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 15615479)

  • 1. [Nonclassic congenital adrenal hyperplasia resulting from 21-hydroxylase deficiency].
    Jesić M; Jesić M; Sajić S; Maglajlić S; Necić S; Bojić V
    Srp Arh Celok Lek; 2004 Oct; 132 Suppl 1():106-8. PubMed ID: 15615479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An update of congenital adrenal hyperplasia.
    New MI
    Ann N Y Acad Sci; 2004 Dec; 1038():14-43. PubMed ID: 15838095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonclassic 21-hydroxylase deficiency.
    Dewailly D
    Semin Reprod Med; 2002 Aug; 20(3):243-8. PubMed ID: 12428204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency revisited: an update with a special focus on adolescent and adult women.
    Carmina E; Dewailly D; Escobar-Morreale HF; Kelestimur F; Moran C; Oberfield S; Witchel SF; Azziz R
    Hum Reprod Update; 2017 Sep; 23(5):580-599. PubMed ID: 28582566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency - management in adults.
    Ambroziak U; Bednarczuk T; Ginalska-Malinowska M; Małunowicz EM; Grzechocińska B; Kamiński P; Bablok L; Przedlacki J; Bar-Andziak E
    Endokrynol Pol; 2010; 61(1):142-55. PubMed ID: 20205117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limited value of serum steroid measurements in identification of mild form of 21-hydroxylase deficiency.
    Török D; Halász Z; Garami M; Homoki J; Fekete G; Sólyom J
    Exp Clin Endocrinol Diabetes; 2003 Feb; 111(1):27-32. PubMed ID: 12605347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonclassic adrenal hyperplasia.
    Speiser PW
    Rev Endocr Metab Disord; 2009 Mar; 10(1):77-82. PubMed ID: 18690539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Congenital adrenal hyperplasia owing to 21-hydroxylase deficiency.
    Speiser PW
    Endocrinol Metab Clin North Am; 2001 Mar; 30(1):31-59, vi. PubMed ID: 11344938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Congenital adrenal hyperplasia].
    Stanić M; Nesović M
    Med Pregl; 1999; 52(11-12):447-54. PubMed ID: 10748766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Health status of adults with congenital adrenal hyperplasia due to 21-hydroxylase deficiency].
    Bachelot A; Touraine P
    Presse Med; 2014 Apr; 43(4 Pt 1):428-37. PubMed ID: 24630263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reproductive outcome of women with 21-hydroxylase-deficient nonclassic adrenal hyperplasia.
    Moran C; Azziz R; Weintrob N; Witchel SF; Rohmer V; Dewailly D; Marcondes JA; Pugeat M; Speiser PW; Pignatelli D; Mendonca BB; Bachega TA; Escobar-Morreale HF; Carmina E; Fruzzetti F; Kelestimur F
    J Clin Endocrinol Metab; 2006 Sep; 91(9):3451-6. PubMed ID: 16822826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late onset congenital adrenal hyperplasia due to 21-hydroxylase deficiency presenting as isolated premature thelarche.
    Zador I
    J Pediatr Endocrinol Metab; 2007 Jan; 20(1):87-90. PubMed ID: 17315534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Congenital adrenal hyperplasia due to 21 hydroxylase deficiency--case report].
    Vlaski J; Katanić D; Kavecan I; Dautović S; Vorgucin I
    Med Pregl; 2008; 61(3-4):183-6. PubMed ID: 18773697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonclassic congenital adrenal hyperplasia due to 21-hydroxylase deficiency: clinical presentation, diagnosis, treatment, and outcome.
    Falhammar H; Nordenström A
    Endocrine; 2015 Sep; 50(1):32-50. PubMed ID: 26082286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 21-hydroxylase-deficient nonclassic adrenal hyperplasia: the great pretender.
    Moran C; Azziz R
    Semin Reprod Med; 2003 Aug; 21(3):295-300. PubMed ID: 14593552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth pattern of untreated boys with simple virilizing congenital adrenal hyperplasia indicates relative androgen insensitivity during the first six months of life.
    Bonfig W; Schwarz HP
    Horm Res Paediatr; 2011; 75(4):264-8. PubMed ID: 21196707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transient hyper-17-hydroxyprogesteronemia: a clinical subgroup of patients diagnosed at neonatal screening for congenital adrenal hyperplasia.
    Cavarzere P; Samara-Boustani D; Flechtner I; Dechaux M; Elie C; Tardy V; Morel Y; Polak M
    Eur J Endocrinol; 2009 Aug; 161(2):285-92. PubMed ID: 19451212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective study of the prevalence of nonclassical congenital adrenal hyperplasia among women presenting with hyperandrogenic symptoms and signs.
    Escobar-Morreale HF; Sanchón R; San Millán JL
    J Clin Endocrinol Metab; 2008 Feb; 93(2):527-33. PubMed ID: 18000084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in diagnosis, treatment, and outcome of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Riepe FG; Sippell WG
    Rev Endocr Metab Disord; 2007 Dec; 8(4):349-63. PubMed ID: 17885806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prevalence of non-classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency in Russian women with hyperandrogenism.
    Grodnitskaya E; Kurtser M
    Hum Fertil (Camb); 2018 Dec; 21(4):281-287. PubMed ID: 28669219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.